Results 81 to 90 of about 15,484 (216)
Lasers in Surgery and Medicine, Volume 58, Issue 9, Page 750-753, November 2026.ABSTRACT Objectives Paronychia is a common and often painful cutaneous adverse event of epidermal growth factor receptor inhibitor therapy that can impair function and quality of life. We report the first known case of amivantamab‐associated paronychia successfully treated with 532‐nm potassium‐titanyl‐phosphate laser.
Emilee M. Dreifus +2 more
wiley +1 more source
Journal of Cosmetic Dermatology, Volume 25, Issue 11, November 2026.ABSTRACT Background Noninvasive radiofrequency (RF) therapy has emerged as a prominent approach for facial rejuvenation due to its ability to stimulate collagen remodeling without epidermal ablation. However, conventional RF systems often rely on high thermal output, posing risks of heat‐induced dermal damage. Objective This study aimed to evaluate the
Rongwei Mao +4 more
wiley +1 more source
Skin Research and Technology, Volume 32, Issue 11, November 2026.ABSTRACT Background Accurate assessment of hidradenitis suppurativa (HS) severity is crucial for individualized management, yet conventional clinical grading may underestimate disease extent due to subclinical lesions. Ultrasound enables visualization of deep abscesses and tunnels and may provide additional prognostic information.
Juncheng Wang +5 more
wiley +1 more source
Recognizing and Managing Isotretinoin-Induced Acne Fulminans without Systemic Symptoms
, 2022 This report describes the case of a 14-year-old female patient who presented with severe nodulocystic acne on the face that started 6 to 8 weeks into treatment with isotretinoin.
Marsh, Bryn M.
core +1 more source
Dermatology ReportsIsotretinoin, widely used for treating severe acne, has also been prescribed off-label for hidradenitis suppurativa (HS). While effective in some cases, isotretinoin is known to cause psychiatric side effects.
Fawaz Aljehani +3 more
doaj +1 more source
Vitiligo Appearing after Oral Isotretinoin Therapy for Acne
, 2018 Isotretinoin is an effective treatment for severe and scarring acne. In this report, we describe a case developing vitiligo after isotretinoin therapy for scarring acne.
Amal A. Kokandi
core +1 more source
Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris
, 2015 Copyright © 2015 American Academy of Physician Assistants. Isotretinoin is the strongest, most effective oral treatment for patients with severe acne vulgaris, with remission rates of 89% and higher.
Reilly, Bridget K., Ritsema, Tamara S.
core +1 more source
Isotretinoin-induced agranulocytosis
, 2007 lsotretinoin is used to treat a spectrum of dermatologic conditions. The present article reports the case of a 15-year-old female patient who exhibited agranulocytosis after the initiation of isotretinoin administration.
FERAHBAS, Ayten +5 more
core +1 more source
Isotretinoin and psychopathology: a review [PDF]
, 2009 Isotretinoin, a synthetic oral retinoid that is used against severe nodulocystic acne, has been associated with various psychiatric side effects such as depression, suicidality and psychotic symptoms.
Panayotis Ferentinos +9 more
core +1 more source
BLEPHAROSPASM INDUCED BY SYSTEMIC ISOTRETINOIN
, 2019 Objective: Isotretinoin (13-cis-retinoic acid), a synthetic analog of vitamin A, is commonly used in the treatment of nodulocytic acne, which is resistant to other treatments. The most common side effects of systemic isotretinoin treatment are dry mucous
SAÇMACI, HİKMET, Gurel, Gulhan
core